ClinVar Miner

Submissions for variant NM_000132.4(F8):c.6956dup (p.Leu2320fs)

dbSNP: rs1475873048
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV001803658 SCV002049506 pathogenic Hereditary factor VIII deficiency disease 2021-04-06 criteria provided, single submitter clinical testing The F8 c.6956dupC; p.Leu2320ValfsTer65 variant (rs1475873048), is reported in the literature in an individual affected with severe hemophilia A (see F8 database and references therein). This variant is absent from the Genome Aggregation Database, indicating it is not a common polymorphism. This variant causes a frameshift by inserting a single nucleotide, so it is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Additionally, another frameshift variant at this codon (c.6956_6957dupCACC, p.Leu2320ThrfsTer66) has been reported in individuals with severe hemophilia A and is considered pathogenic (Guo 2018). Based on available information, this variant is considered to be pathogenic. References: Link to Factor VIII database: https://f8-db.eahad.org/index.php Guo Z et al. Spectrum of Molecular Defects in 216 Chinese Families With Hemophilia A: Identification of Noninversion Mutation Hot Spots and 42 Novel Mutations. Clin Appl Thromb Hemost. 2018 Jan;24(1):70-78. PMID: 28056528.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV001803658 SCV004803979 likely pathogenic Hereditary factor VIII deficiency disease 2024-01-30 criteria provided, single submitter clinical testing Variant summary: F8 c.6956dupC (p.Leu2320ValfsX65) causes a frameshift which results in an extension of the protein. The variant was absent in 182967 control chromosomes (gnomAD). c.6956dupC has been reported in the literature in at least one individual affected with Factor VIII Deficiency (Hemophilia A) (e.g., Johnsen_2017, F8 database (https://dbs.eahad.org/)). FVIII:C activity in this individual was also reported to be <1%. The following publication have been ascertained in the context of this evaluation (PMID: 29296726). ClinVar contains an entry for this variant (Variation ID: 1330566). Additionally, several upstream and downstream variants resulting in the same protein extension (e.g., c.6988dupC/p.Gln2330Profs*55, c.6994dupT/p.Trp2332Leufs*53, c.7006dupA/p.Ile2336Asnfs*49) have been reported in the patients with Hemophilia A (HGMD). Based on the evidence outlined above, the variant was classified as likely pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.